Comgest Global Investors S.A.S. Has $1.91 Million Stock Holdings in Relx Plc $RELX

Comgest Global Investors S.A.S. reduced its position in Relx Plc (NYSE:RELX) by 30.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 39,893 shares of the technology company’s stock after selling 17,075 shares during the period. Comgest Global Investors S.A.S.’s holdings in Relx were worth $1,905,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in RELX. NewSquare Capital LLC increased its position in Relx by 522.0% in the second quarter. NewSquare Capital LLC now owns 566 shares of the technology company’s stock worth $31,000 after purchasing an additional 475 shares during the period. Caitong International Asset Management Co. Ltd grew its position in shares of Relx by 99.3% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 608 shares of the technology company’s stock worth $33,000 after buying an additional 303 shares during the period. Salomon & Ludwin LLC grew its position in shares of Relx by 1,646.2% during the 3rd quarter. Salomon & Ludwin LLC now owns 681 shares of the technology company’s stock worth $32,000 after buying an additional 642 shares during the period. Nisa Investment Advisors LLC raised its stake in shares of Relx by 191.7% during the third quarter. Nisa Investment Advisors LLC now owns 700 shares of the technology company’s stock worth $33,000 after buying an additional 460 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC acquired a new position in Relx in the second quarter valued at approximately $38,000. Institutional investors own 15.02% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on RELX shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Relx in a report on Monday, December 29th. Citigroup began coverage on Relx in a research note on Monday, January 12th. They set a “neutral” rating for the company. Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research note on Sunday. Zacks Research upgraded Relx from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 6th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research note on Monday, February 2nd. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Relx currently has an average rating of “Buy”.

Relx Stock Up 0.3%

RELX stock opened at $30.54 on Thursday. Relx Plc has a 1-year low of $27.57 and a 1-year high of $56.33. The business’s 50-day moving average price is $37.95 and its two-hundred day moving average price is $42.60. The company has a current ratio of 0.49, a quick ratio of 0.44 and a debt-to-equity ratio of 2.38.

Relx (NYSE:RELX) last released its quarterly earnings data on Thursday, February 12th. The technology company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.85 by ($0.42). The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $6.70 billion. On average, research analysts expect that Relx Plc will post 1.68 earnings per share for the current year.

Relx Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, June 24th. Stockholders of record on Friday, May 8th will be given a dividend of $0.6559 per share. The ex-dividend date of this dividend is Friday, May 8th. This represents a dividend yield of 422.0%.

Relx Company Profile

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.